← Back to Search

Vaccine

HPV Vaccination Promotion for Young Adults in Texas

Q: Could I be considered a participant in this medical research?

<p>Eligible candidates must suffer from a <a href="https://www.withpower.com/clinical-trials/cancer">cancer</a>-related malady and be aged between 18 to 26. The research team is currently searching for roughly 1200 participants for their clinical trial.</p>

N/A

Recruiting

Led By Qian Lu

Research Sponsored by M.D. Anderson Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age 18-26 years

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up through study completion, an average of 1 year

Awards & highlights

Study Summary

This trial will test a new way to get more young adults vaccinated against HPV. They will track how many people start and finish the vaccine by 3 and 9 months.

Who is the study for?

This trial is for young adults aged 18-26 in Texas who haven't had the HPV vaccine yet. They must read English, have internet access via a smart device, and be enrolled in a participating school for at least 9 months. Pregnant individuals or those with severe allergies to vaccine ingredients cannot join.Check my eligibility

What is being tested?

The study is testing different ways to increase HPV vaccination rates among young adults using a randomized controlled trial (RCT). Participants will be randomly placed into one of five experimental groups to see which method works best over the course of nine months.See study design

What are the potential side effects?

While not specified here, common side effects of HPV vaccines can include pain at the injection site, headaches, fever, nausea, and dizziness. Severe allergic reactions are rare but possible.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 18 and 26 years old.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ through study completion, an average of 1 year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~through study completion, an average of 1 year

This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

The two will be the rate of HPV vaccination initiation by 3-month follow-up and rate of HPV vaccination completion by 9-month follow-up

Trial Design

6Treatment groups

Experimental Treatment

Active Control

Group I: Experimental arm 5Experimental Treatment1 Intervention

Written narrative Persuasion

Group II: Experimental arm 4Experimental Treatment1 Intervention

Video narrative persuasion; Enhanced Access to HPV vaccines

Group III: Experimental arm 3Experimental Treatment1 Intervention

Enhanced Access to HPV vaccines

Group IV: Experimental arm 2Experimental Treatment1 Intervention

Written narrative Persuasion

Group V: Experimental arm 1Experimental Treatment1 Intervention

Video narrative persuasion

Group VI: Control/ active comparator Arm 6Active Control1 Intervention

CDC information

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH

13,665 Previous Clinical Trials

40,924,654 Total Patients Enrolled

M.D. Anderson Cancer CenterLead Sponsor

2,973 Previous Clinical Trials

1,788,146 Total Patients Enrolled

Qian LuPrincipal InvestigatorM.D. Anderson Cancer Center

3 Previous Clinical Trials

464 Total Patients Enrolled

Media Library

Human Papillomavirus Clinical Trial 2023: HPV Vaccine Highlights & Side Effects. Trial Name: NCT05057312 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are researchers still seeking participants for this experiment?

"As per clinicaltrials.gov, this experiment is actively recruiting patients. The initial post was on July 26 2021 and the information has been refreshed as of July 9th 2022."

Answered by AI

Could I be considered a participant in this medical research?

"Eligible candidates must suffer from a cancer-related malady and be aged between 18 to 26. The research team is currently searching for roughly 1200 participants for their clinical trial."

Answered by AI

How many individuals have volunteered for this experiment?

"Affirmative. Clinicaltrials.gov information indicates that the trial, initially posted on July 26th 2021, is still recruiting participants. At this time they are seeking 1200 patients at a single facility."

Answered by AI